10月16日，Moderna盘中下跌4.12%，报226.69美元/股，成交额3.83亿美元。
消息面上，市场对其mRNA癌症疫苗与K药联合疗法III期阳性结果及商业化预期已持续交易，在股价年内大涨逾650%后，短线资金获利了结压力升温。
与此同时，期权市场当日出现1170万美元远期虚值CALL卖出，大单情绪偏谨慎，交易者更倾向押注股价在250美元上方承压，反映在ESMO年会及完整数据公布前，部分资金对继续上攻保持克制。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.